Blind trial

In a blind or blinded experiment, information which may influence the participants of the experiment is withheld until after the experiment is complete. Good blinding can reduce or eliminate experimental biases that arise from participants' expectations, observer's effect on the participants, observer bias, confirmation bias, and other sources. A blind can be imposed on any participant of an experiment, including subjects, researchers, technicians, data analysts, and evaluators. In some cases, while blinding would be useful, it is impossible or unethical. For example, it is not possible to blind a patient to their treatment in a physical therapy intervention. A good clinical protocol ensures that blinding is as effective as possible within ethical and practical constraints.

 

  • A type of clinical trial in which neither the participants nor the researcher knows which treatment or intervention participants are receiving until the clinical trial is over. This makes results of the study less likely to be biased. This means that the

Related Conference of Blind trial

March 27-28, 2024

6th International Conference on Digital Health

London, UK
April 24-25, 2024

35th European Heart and Heart Failure Congress

Paris, France
June 21-22, 2024

52nd Global Nursing & Healthcare Conference

Rome, Italy
September 09-10, 2024

3rd Global Summit on Physiology and Metabolism of Thyroid

Paris, France
September 18-19, 2024

29th International Conference on Skincare and Cosmetology

Amsterdam, Netherlands
September 19-20, 2024

20th Global Biomarkers and Clinical Research Summit

Amsterdam, Netherlands
September 24-25, 2024

5th Global Summit on Public Health

Paris, France

Blind trial Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in